Hulk , I don't know if they will do pre-clinical s
Post# of 148183
but those studies are really not expensive , then approval of phase 2 and wait for partner , but company value went up,
And it will not change anything else....
So personally I think different . Globally COPD is in about 25 Bill a year market ....
And as always IMO only....